Background Omalizumab, a recombinant anti-IgE antibody, effectively treats chronic
spontaneous urticaria. Evidence is lacking in patients with chronic inducible urticarias …

Urticaria is a common clinical condition presenting with wheals (hives), angioedema, or
both. Urticaria has a complex pathogenesis, along with a high disease burden, a significant …

The Montreal Protocol has limited increases in the UV-B (280–315 nm) radiation reaching
the Earth's surface as a result of depletion of stratospheric ozone. Nevertheless, the …

There are a number of systemic disorders that can manifest with urticarial skin lesions,
including urticarial vasculitis, connective tissue diseases, hematologic diseases, and …

Developments increasing our understanding of chronic urticaria have resulted in the
simplification and improvement of available treatments. Currently, many treatments target …

The physical urticarias are a heterogeneous subgroup of chronic urticarias in which wheals
can be reproducibly induced by different specific physical stimuli such as cold, heat …

Background Sunlight induces a wide variety of dermatoses. Their differential diagnosis is
problematic not only because of similar phenotypes, but also because of confusing …

Photoprotection is a critical health prevention strategy to reduce the deleterious effects of
ultraviolet radiation (UVR) and visible light (VL). Methods of photoprotection are reviewed in …

Vemurafenib is a new‐targeted therapy approved for the treatment of patients with V 600 E
BRAF‐mutant metastatic melanoma. Among the cutaneous adverse events reported, the …

Background Until now, photoprotection of human skin has involved the development of
sunscreens effective in the ultraviolet (UV) domain. During the last ten years, several studies …